Dysregulation of ILC3s unleashes progression and immunotherapy resistance in colon cancer.
Cell. 2021 Sep 16;184(19):5015-5030.e16. doi: 10.1016/j.cell.2021.07.029. Epub 2021 Aug 17.
Cell. 2021.
PMID: 34407392
Free PMC article.